Jpmorgan Chase & CO Senseonics Holdings, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SENS
# of Institutions
142Shares Held
59.9MCall Options Held
393KPut Options Held
254K-
Vanguard Group Inc Valley Forge, PA23.5MShares$7.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$2.5 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$2.1 Million0.12% of portfolio
-
Geode Capital Management, LLC Boston, MA5.84MShares$1.75 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.06MShares$919,4560.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $140M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...